Group One Trading’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Group One Trading’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-967	Closed	-$11.8K	–	9185
2021 Q4	$14K	Sell	967 -328	-25%	-$7.77K	﹤0.01%	7206
2021 Q3	$39K	Sell	1,295 -200	-13%	-$5.65K	﹤0.01%	6751
2021 Q2	$50K	Sell	1,495 -922	-38%	-$34.3K	﹤0.01%	6588
2021 Q1	$100K	Buy	+2,417	New	+$150K	﹤0.01%	5670
2020 Q2	–	Sell	-7	Closed	-$1.17K	–	6450
2020 Q1	$1K	Buy	+7	New	+$2.14K	﹤0.01%	5155
2019 Q3	–	Hold	0	–	–	–	5790
2019 Q2	–	Hold	0	–	–	–	5638
2018 Q4	–	Sell	-1	Closed	-$538	–	5694
2018 Q3	$1K	Sell	1 -1	-50%	-$709	﹤0.01%	5106
2018 Q2	$2K	Buy	+2	New	+$2.29K	﹤0.01%	4974

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Group One Trading's NBRV Position: Q1 2022 in Review

Group One Trading sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2022, closing a stake of 967 shares — an estimated $11.8K sold.

Group One Trading first reported a position in NBRV in Q2 2018 and held it in 7 quarters. The position peaked at $100K in Q1 2021. 29 funds tracked by Wall St. Rank hold NBRV as of Q1 2022.

Group One Trading reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2022 after selling out during the quarter.
Group One Trading sold 967 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2022, an estimated $11.8K.
Group One Trading first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2018 and held it in 7 quarters.
Group One Trading's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $100K in Q1 2021.
29 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.